2013 Annual Meeting | S28 - Epilepsy: Imaging and Electrophysiology
| 02:00 PM - 03:45 PM | Abstract |
001 - Epileptic Networks in Temporal Lobe Epilepsy by Functional and Structural Images
Ana C. Coan, MD |
| 02:00 PM - 03:45 PM | Abstract |
002 - A Novel Method To Map Interictal Epileptiform Discharges from Simultaneous EEG-fMRI Data
Junjie Liu |
| 02:00 PM - 03:45 PM | Abstract |
003 - Combining fMRI Language Lateralization and Hippocampal Morphometry for Predicting Verbal Memory Outcome after Left Temporal Lobectomy
Patrick M. Bauer, MD |
| 02:00 PM - 03:45 PM | Abstract |
004 - Population Statistics-Based SPECT Analysis in Nonlesional Extratemporal Lobe Epilepsy
Vlastimil Sulc |
| 02:00 PM - 03:45 PM | Abstract |
005 - Correlation of Focal MRI Findings and Seizure Outcomes in PRES
Brian Moran, MD |
| 02:00 PM - 03:45 PM | Abstract |
006 - Alpha-gamma Frequencies and Their Possible Role in Seizure Evolution
John R. Jefferson, MD |
| 02:00 PM - 03:45 PM | Abstract |
007 - Timing of EEG in Correlation to Prognosis in Postcardiac Arrest Therapeutic Hypothermia Patients
Tapan R. Kavi, MD |
| Martha Morrell, MD, FAAN | Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health. |
| Gregory D. Cascino, MD, FAAN | Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. |
| Erik J. Kobylarz, MD, PhD | No disclosure on file |
| David Sabsevitz | No disclosure on file |
| No disclosure on file | |
| Fernando Cendes, MD, PhD, FAAN | Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH. |
| Matthew Senjem | Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic. |
| Manoj Raghavan, MD, PhD | No disclosure on file |
| Ana C. Coan, MD | No disclosure on file |
| Jeffrey M. Chung, MD, FAAN | Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Asvar Law. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Oak Crest Institute of Science. |
| Evgeny Tsimerinov, MD, PhD, FAAN | No disclosure on file |
| Clarissa L. Yasuda, MD, PhD | Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS. |
| Gregory A. Worrell, MD | Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. |
| Zhiyi Sha, MD, PhD | No disclosure on file |
| Jeffrey W. Britton, MD, FAAN | Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society. |
| Junjie Liu | No disclosure on file |
| Jeffrey Binder, MD | No disclosure on file |
| Dawn Eliashiv, MD, FAAN | Dr. Eliashiv has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for eisai. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic's. Dr. Eliashiv has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. The institution of Dr. Eliashiv has received research support from NINDS. The institution of Dr. Eliashiv has received research support from Neuropace. Dr. Eliashiv has received publishing royalties from a publication relating to health care. |
| John R. Jefferson, MD | Dr. Jefferson has nothing to disclose. |
| Elson L. So, MD, FAAN | Dr. So has nothing to disclose. |
| Benjamin H. Brinkmann, PhD | Dr. Brinkmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care. |
| Brian Moran, MD | No disclosure on file |
| Patrick M. Bauer, MD | No disclosure on file |
| David T. Jones, MD | Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. |
| Lily Wong-Kisiel, MD, FAAN | Dr. Wong-Kisiel has nothing to disclose. |
| Barbara C. Jobst, MD, PhD, FAAN | Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from Harvard Pilgrim. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC. |
| Thomas R. Henry, MD, FAAN | Dr. Henry has nothing to disclose. |
| Anthony Traboulsee, MD | Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers. |
| Tapan R. Kavi, MD | No disclosure on file |
| Chunyang Wang, MD MS | No disclosure on file |
| Vlastimil Sulc | No disclosure on file |
| David K. Li, MD | Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers. |
| Terrance Darcey | No disclosure on file |
| John J. Kelly, Jr., MD | No disclosure on file |
| Melissa A. Carran, MD | Dr. Carran has nothing to disclose. |
| Galina Vorobeychik, MD, FRCPC, FAAN | Dr. Vorobeychik has nothing to disclose. |
| Stefano Jann, MD | No disclosure on file |
| Pieter Van Doorn, MD | The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anexxon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. Dr. Van Doorn has received publishing royalties from a publication relating to health care. |